Sort   by:  
 Page size 
UnknownPrioritization of Randomized Clinical Trial Questions for Children Hospitalized With Common Conditions: A Consensus Statement.
Not available
S-EPMC12857807 | biostudies-literature
UnknownTargeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial.
Not available
S-EPMC3957186 | biostudies-literature
UnknownChallenges and barriers to optimising sedation in intensive care: a qualitative study in eight Scottish intensive care units.
Not available
S-EPMC6538047 | biostudies-literature
UnknownLow-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data.
Not available
S-EPMC6610026 | biostudies-literature
UnknownLow-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes.
Not available
S-EPMC6105329 | biostudies-literature
UnknownCo-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
Not available
S-EPMC3462593 | biostudies-literature
UnknownA new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history.
Not available
S-EPMC4302258 | biostudies-literature
UnknownAcceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants.
Not available
S-EPMC3837047 | biostudies-literature
UnknownAntigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.
Not available
S-EPMC3580128 | biostudies-literature
UnknownPioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Not available
S-EPMC4887756 | biostudies-literature
Sort   by:  
 Page size